Capsaicin 8% patch treatment for amputation stump and phantom limb pain: a clinical and functional MRI study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28761369)

Published in J Pain Res on July 13, 2017

Authors

Rosario Privitera1, Rolfe Birch1, Marco Sinisi2, Iordan R Mihaylov3, Robert Leech4, Praveen Anand1

Author Affiliations

1: Peripheral Neuropathy Unit, Centre for Clinical Translation, Hammersmith Hospital, Imperial College London, London, UK.
2: Peripheral Nerve Injury Unit, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK.
3: Department of Pain Medicine, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK.
4: Computational, Cognitive and Clinical Neuroimaging Laboratory, Division of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK.

Articles cited by this

Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79

Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage (2002) 38.46

FSL. Neuroimage (2011) 15.56

The short-form McGill Pain Questionnaire. Pain (1987) 14.40

Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature (1995) 3.44

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol (2008) 2.60

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology (2008) 2.48

Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther (2004) 2.42

Mirrored, imagined and executed movements differentially activate sensorimotor cortex in amputees with and without phantom limb pain. Pain (2010) 2.05

Phantom pain is associated with preserved structure and function in the former hand area. Nat Commun (2013) 2.02

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth (2011) 1.95

Phantom pain and risk factors: a multivariate analysis. J Pain Symptom Manage (2002) 1.80

Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology (2008) 1.65

Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil (2005) 1.64

Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation. Arch Phys Med Rehabil (2000) 1.61

Phantom movements and pain. An fMRI study in upper limb amputees. Brain (2001) 1.53

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med (2010) 1.50

Phantom limb pain, cortical reorganization and the therapeutic effect of mental imagery. Brain (2008) 1.50

Prosthesis use in persons with lower- and upper-limb amputation. J Rehabil Res Dev (2008) 1.34

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med (2010) 1.31

The influence of preamputation pain on postamputation stump and phantom pain. Pain (1997) 1.29

Acceleration of wound healing with high voltage, monophasic, pulsed current. Phys Ther (1988) 1.25

Phantom pain and health-related quality of life in lower limb amputees. J Pain Symptom Manage (2002) 1.23

The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med (1996) 1.19

Preamputation pain and acute pain predict chronic pain after lower extremity amputation. J Pain (2006) 1.14

Disentangling motor execution from motor imagery with the phantom limb. Brain (2012) 1.12

Cortical reorganization and phantom phenomena in congenital and traumatic upper-extremity amputees. Exp Brain Res (1998) 1.10

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage (2010) 1.08

The effect of opioids on phantom limb pain and cortical reorganization. Pain (2001) 1.07

Cortical reorganization in motor cortex after graft of both hands. Nat Neurosci (2001) 1.07

Phantom limb: a phenomenological study. Br J Psychiatry (1982) 1.03

Network-level reorganisation of functional connectivity following arm amputation. Neuroimage (2015) 1.02

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study. Eur J Pain (2013) 1.02

A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J Peripher Nerv Syst (2001) 1.02

Painful and nonpainful phantom and stump sensations in acute traumatic amputees. J Trauma (2008) 1.01

Reorganizational and perceptional changes after amputation. Brain (1996) 1.01

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit (2009) 1.01

Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol (2007) 1.00

Documentation of wound surface area from tracings of wound perimeters. Clinical report on three techniques. Phys Ther (1983) 0.99

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. J Pain (2010) 0.98

Factors associated with phantom limb pain: a 31/2-year prospective study. Clin Rehabil (2010) 0.97

Amputees "neglect" the space near their missing hand. Psychol Sci (2009) 0.95

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Curr Med Res Opin (2013) 0.94

Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med (2002) 0.94

[Prevalence and risk factors of phantom limb pain and phantom limb sensations in Germany. A nationwide field survey]. Schmerz (2009) 0.93

Affective distress and amputation-related pain among older men with long-term, traumatic limb amputations. J Pain Symptom Manage (2006) 0.92

Phantom tooth pain: a new look at an old dilemma. Pain Med (2000) 0.91

Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil (2004) 0.91

The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds. J Clin Neurosci (2001) 0.90

Reassessing cortical reorganization in the primary sensorimotor cortex following arm amputation. Brain (2015) 0.90

Occurrence of phantom genitalia after gender reassignment surgery. Med Hypotheses (2007) 0.90

Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology (2005) 0.89

Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial. Pain (2003) 0.89

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain. Diabetes Res Clin Pract (2011) 0.89

Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. J Rehabil Res Dev (2006) 0.88

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther (2013) 0.86

Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Pain (2013) 0.85

Cortical motor activity and reorganization following upper-limb amputation and subsequent targeted reinnervation. Neuroimage Clin (2013) 0.84

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain. J Pain Res (2012) 0.84

Phantom breast sensations and phantom breast pain: a 2-year prospective study and a methodological analysis of literature. Eur J Pain (2006) 0.84

Stability of phantom limb phenomena after upper limb amputation: a longitudinal study. Neuroscience (2008) 0.83

A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg (2004) 0.83

Structural plasticity and reorganisation in chronic pain. Nat Rev Neurosci (2016) 0.82

Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain (2014) 0.82

Primary motor cortex changes after amputation correlate with phantom limb pain and the ability to move the phantom limb. Neuroimage (2016) 0.81

Claimed walking distance of lower limb amputees. Disabil Rehabil (2005) 0.81

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia. BMC Anesthesiol (2011) 0.81

NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study. Clin J Pain (2014) 0.80

Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience. Pain Manag (2012) 0.80

Phantom-related phenomena after rectal amputation: prevalence and clinical characteristics. Pain (1991) 0.79

The relationship of phantom limb pain to other phantom limb phenomena in upper extremity amputees. Pain (1997) 0.79

Five early accounts of phantom limb in context: Paré, Descartes, Lemos, Bell, and Mitchell. Neurosurgery (2003) 0.79

Idiopathic headache as a possible risk factor for phantom tooth pain. Headache (1991) 0.79

Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev (2016) 0.78

A computational model unifies apparently contradictory findings concerning phantom pain. Sci Rep (2014) 0.78

Hypoesthesia in the distal residual limb of amputees. PM R (2010) 0.78

Dissociation of phantom limb phenomena from stump tactile spatial acuity and sensory thresholds. Brain (2005) 0.78

The effects of mirror therapy on pain and motor control of phantom limb in amputees: A systematic review. Ann Phys Rehabil Med (2016) 0.78

Phantom testis syndrome: prevalence, phenomenology and putative mechanisms. Int J Androl (2009) 0.77

Psychological distress in amputees with phantom limb pain. J Pain Symptom Manage (2001) 0.76

Phantom breast syndrome. Indian J Palliat Care (2009) 0.76

[Capsaicin 8 % cutaneous patches for phantom limb pain. Results from everyday practice (non-interventional study)]. Schmerz (2014) 0.76

Phantom gallbladder. A variant of the rim sign. Clin Nucl Med (1987) 0.76

Stability of Sensory Topographies in Adult Cortex. Trends Cogn Sci (2017) 0.76

Changes in thermal and mechanical pain thresholds in hand amputees. A clinical and physiological long-term follow-up. Pain (1990) 0.76

Tactile, thermal, and electrical thresholds in patients with and without phantom limb pain after traumatic lower limb amputation. J Pain Res (2015) 0.75